Nathaniel P Katz
Overview
Explore the profile of Nathaniel P Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
5607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update
Langford D, Baron R, Edwards R, Gewandter J, Gilron I, Griffin R, et al.
Pain
. 2023 Jun;
164(9):1927-1930.
PMID: 37288944
No abstract available.
2.
Langford D, Lou R, Sheen S, Amtmann D, Colloca L, Edwards R, et al.
J Pain
. 2022 Dec;
24(4):575-581.
PMID: 36577461
Variability in pain-related outcomes can hamper assay sensitivity of chronic pain clinical trials. Expectations of outcome in such trials may account for some of this variability, and thereby impede development...
3.
Ross E, Katz N, Conaghan P, Kivitz A, Turk D, Spitzer A, et al.
Pain Ther
. 2021 Nov;
11(1):289-302.
PMID: 34791634
Introduction: A phase 3 randomized controlled study comparing triamcinolone acetonide extended-release (TA-ER) to conventional TA crystalline suspension (TAcs) reported variable efficacy results. Enrollment criteria may have contributed to this discrepancy,...
4.
Kleykamp B, Dworkin R, Turk D, Bhagwagar Z, Cowan P, Eccleston C, et al.
Pain
. 2021 Sep;
163(6):1006-1018.
PMID: 34510135
Chronic pain clinical trials have historically assessed benefit and risk outcomes separately. However, a growing body of research suggests that a composite metric that accounts for benefit and risk in...
5.
Farrar J, Bilker W, Cochetti P, Argoff C, Haythornthwaite J, Katz N, et al.
Pain
. 2021 Jul;
163(1):47-57.
PMID: 34261978
Opioids relieve acute pain, but there is little evidence to support the stability of the benefit over long-term treatment of chronic noncancer pain. Previous systematic reviews consider only group level...
6.
Gewandter J, Smith S, Dworkin R, Turk D, Gan T, Gilron I, et al.
Pain
. 2021 Apr;
162(11):2669-2681.
PMID: 33863862
Randomized clinical trials have demonstrated the efficacy of opioid analgesics for the treatment of acute and chronic pain conditions, and for some patients, these medications may be the only effective...
7.
Gewandter J, McDermott M, Evans S, Katz N, Markman J, Simon L, et al.
Pain
. 2021 Jan;
162(7):1899-1905.
PMID: 33449513
No abstract available.
8.
Erpelding N, Evans K, Lanier R, Elder H, Katz N
Clin J Pain
. 2020 Aug;
36(12):950-954.
PMID: 32841968
Objective: A literature review was conducted to compare placebo responses in a recent trial-which implemented an accurate pain reporting (APR) and placebo response reduction (PRR) training program-with placebo responses in...
9.
Gandhi K, Wei W, Huang A, Wang L, Iyer R, Katz N
Clinicoecon Outcomes Res
. 2020 Jul;
12:285-297.
PMID: 32606845
Background: Although opioids may be used in the management of pain in patients with osteoarthritis (OA), there is a dearth of real-world data characterizing opioid regimen failure in these patients....
10.
As-Sanie S, Soliman A, Evans K, Erpelding N, Lanier R, Katz N
J Minim Invasive Gynecol
. 2020 Jun;
28(2):297-306.e2.
PMID: 32531340
Study Objective: To determine the prevalence and pattern of opioid use in endometriosis and the characteristics of patients prescribed an opioid using medical insurance claims data. Design: We performed a...